Literature DB >> 26538524

Tenofovir alafenamide for HIV: time to switch?

Shireesha Dhanireddy1, Jared M Baeten2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26538524     DOI： 10.1016/S1473-3099(15)00412-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies.

Authors:  Victor E Mulanovich; Parth A Desai; Uday R Popat
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

2.  Hormonal Contraceptives Differentially Suppress TFV and TAF Inhibition of HIV Infection and TFV-DP in Blood and Genital Tract CD4+ T cells.

Authors:  Zheng Shen; Marta Rodriguez-Garcia; Mickey V Patel; Jack Bodwell; Angela D M Kashuba; Charles R Wira
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

3.  Tenofovir Inhibits Wound Healing of Epithelial Cells and Fibroblasts from the Upper and Lower Human Female Reproductive Tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Zheng Shen; Jack Bodwell; Richard M Rossoll; Charles R Wira
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.